Cyclosporine was first described in 1976 as a fungal metabolite and found to have remarkable immunosuppressive properties both experimentally and clinically. It was several years later that at the University of California, Irvine, College of Medicine, Drs. Kirby Black (Research Director for the Plastic Surgery Division within the Department of Surgery) and Charles W. Hewitt (Director of Research for the Division of Urology within the Department of Surgery) found themselves next door to one another, each directing the research efforts of their respective divisions. Dr. Black's interests at the time were in developing models of ischemia reperfusion injury and flap studies in the field of Plastic Surgery and Dr. Hewitt's primary interests were in studying transplant rejection and mechanisms of tolerance induction, as the Division of Urology was the division that was primarily responsible for kidney transplantation at the University of California, Irvine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. F. Borel, C. Feurer, H. U. Gubler, et al., Biological effects of cyclosporine A: A new anti-lymphocytic agent, Agents Actions 468 (1976).
K. S. Black, C. W. Hewitt, T. L. Woodard, et al., Efforts to enhance survival of limb allografts by prior administration of whole blood in rats using a new survival end-point, J Microsurg 3, 162–167 (1982).
C. W. Hewitt, K. S. Black, L. A. Fraser, et al., Cyclosporin A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival, Transplant Proc 15, 514–517 (1983).
J. F. Borel, C. Feurer, H. U. Gubler, et al., Biological effects of cyclosporine A: A new anit-lymphocytic agent, Agents Actions 6, 468 (1976).
A. K. Gulati, A. A. Zalewski, Muscle allograft survival after cyclosporin A immuno-suppression, Exp Neurol 77, 378 (1982).
A. W. Thomson, I. D. Cameron, Immune suppression with cyclosporin A-optimism and caution, Scott Med J 26(2), 139–144 (1981).
B. D. Kahan, Cyclosporine: the agent and its actions, Transplant Proc 17(4), 5–18 (1985).
K. S. Black, C. W. Hewitt, L. A. Fraser, et al., Cosmas and Damian in the laboratory, N Engl J Med 306, 368–369 (1982).
C. W. Hewitt, K. S. Black, L. A. Fraser, et al., Composite tissue (limb) allografts in rats: I. Dose-dependent increase in survival with cyclosporine, Transplantation 39, 360–364 (1985).
K. S. Black, C. W. Hewitt, L. A. Fraser, et al., Composite tissue (limb) allografts in rats: II. Indefinite survival using low dose cyclosporine, Transplantation 39, 365–368 (1985).
B. D. Kahan, Cosmas and Damian in the 20th Century, N Engl J Med 305(5), 280–281 (1981).
B. D. Kahan, Cosmas and Damian revisited, Transplant Proc 4(Suppl 1), 2211 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Salgado, C.J., Mardini, S., Hewitt, C.W. (2008). The First Limb Transplants with Cyclosporine. In: Hewitt, C.W., Lee, W.P.A., Gordon, C.R. (eds) Transplantation of Composite Tissue Allografts. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-74682-1_4
Download citation
DOI: https://doi.org/10.1007/978-0-387-74682-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-74681-4
Online ISBN: 978-0-387-74682-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)